Olon is an API and finished-dose manufacturer based in Italy. It holds 167 active US drug master files and 80 valid CEPs. Its filings concentrate with MINSA (CR), NCELS (KZ) and BOMRA (BW). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 10 October 2025 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Raigad, India | 3005983749 |
| Rodano, Italy | Not on file |
| SETTIMO TORINESE, Italy | Not on file |
| DORNO, Italy | Not on file |
| CASALETTO LODIGIANO, Italy | Not on file |
| GARBAGNATE MILANESE, Italy | Not on file |
13 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Diclofenac | EDQM, SFDA (Saudi Arabia), US FDA | 6 |
| Fluoxetine | EDQM, US FDA | 5 |
| Hydroxyurea | EDQM, SFDA (Saudi Arabia), US FDA | 5 |
| Lipoic Acid | EDQM, SFDA (Saudi Arabia), US FDA | 5 |
| Tretinoin | EDQM, SFDA (Saudi Arabia), US FDA | 5 |
| Valganciclovir | SFDA (Saudi Arabia), US FDA | 5 |
| Acyclovir | EDQM, US FDA | 4 |
| Fenofibrate | EDQM, US FDA | 4 |
| Loperamide | EDQM, US FDA | 4 |
| Miconazole | EDQM, US FDA | 4 |
| Terbinafine | EDQM, US FDA | 4 |
| Timolol | EDQM, SFDA (Saudi Arabia), US FDA | 4 |
| Acamprosate | EDQM, US FDA | 3 |
| Acitretin | EDQM, US FDA | 3 |
| Bezafibrate | EDQM, US FDA | 3 |
| Ciclopirox | EDQM, US FDA | 3 |
| Isotretinoin | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Ketotifen | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Labetalol | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Minoxidil | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Quetiapine | EDQM, US FDA | 3 |
| Rifampin | EDQM, US FDA | 3 |
| Rifamycin | US FDA | 3 |
| Rifaximin | EDQM, US FDA | 3 |
| Tamoxifen | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Aceclidine | US FDA | 2 |
| Adapalene | EDQM, US FDA | 2 |
| Albuterol | EDQM, US FDA | 2 |
| Amiloride | EDQM, US FDA | 2 |
| Amitriptyline | EDQM, US FDA | 2 |
| Amorolfine | EDQM, SFDA (Saudi Arabia) | 2 |
| Aripiprazole | EDQM, US FDA | 2 |
| Betahistine Dihydrochloride | EDQM, SFDA (Saudi Arabia) | 2 |
| Betaxolol | EDQM, US FDA | 2 |
| Bumetanide | EDQM, US FDA | 2 |
| Bupropion | US FDA | 2 |
| Choline Fenofibrate | US FDA | 2 |
| Clidinium | US FDA | 2 |
| Clofazimine | US FDA | 2 |
| Clotrimazole | EDQM, US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 7 | None |
| NCELS (KZ) | 2 | None |
| BOMRA (BW) | 1 | None |
| US FDA | None | 3 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Olon comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.